Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 87

1.

Coenzyme Q10 prevents oxidative stress and fibrosis in isoprenaline induced cardiac remodeling in aged rats.

Ulla A, Mohamed MK, Sikder B, Rahman AT, Sumi FA, Hossain M, Reza HM, Rahman GMS, Alam MA.

BMC Pharmacol Toxicol. 2017 Apr 20;18(1):29. doi: 10.1186/s40360-017-0136-7.

2.

Excess mortality rate associated with hepatitis C virus infection: A community-based cohort study in rural Egypt.

Mostafa A, Shimakawa Y, Medhat A, Mikhail NN, Chesnais CB, Arafa N, Bakr I, El Hoseiny M, El-Daly M, Esmat G, Abdel-Hamid M, Mohamed MK, Fontanet A.

J Hepatol. 2016 Jun;64(6):1240-6. doi: 10.1016/j.jhep.2016.02.033. Epub 2016 Feb 26.

PMID:
26921686
3.

Hepatitis C virus infection and risk factors in health-care workers at Ain Shams University Hospitals, Cairo, Egypt.

Okasha O, Munier A, Delarocque-Astagneau E, El Houssinie M, Rafik M, Bassim H, Hamid MA, Mohamed MK, Fontanet A.

East Mediterr Health J. 2015 May 19;21(3):199-212.

PMID:
26074220
4.

How to optimize hepatitis C virus treatment impact on life years saved in resource-constrained countries.

Obach D, Yazdanpanah Y, Esmat G, Avihingsanon A, Dewedar S, Durier N, Attia A, Anwar WA, Cousien A, Tangkijvanich P, Eholié SP, Doss W, Mostafa A, Fontanet A, Mohamed MK, Deuffic-Burban S.

Hepatology. 2015 Jul;62(1):31-9. doi: 10.1002/hep.27691. Epub 2015 Feb 27.

PMID:
25581111
5.

Hepatitis C virus acquisition among Egyptians: analysis of a 10-year surveillance of acute hepatitis C.

Mohsen A, Bernier A, LeFouler L, Delarocque-Astagneau E, El-Daly M, El-Kafrawy S, El-Mango S, Abdel-Hamid M, Gadallah M, Esmat G, Mohamed MK, Fontanet A.

Trop Med Int Health. 2015 Jan;20(1):89-97. doi: 10.1111/tmi.12410. Epub 2014 Oct 22.

6.

Effect of preventive and curative interventions on hepatitis C virus transmission in Egypt (ANRS 1211): a modelling study.

Breban R, Arafa N, Leroy S, Mostafa A, Bakr I, Tondeur L, Abdel-Hamid M, Doss W, Esmat G, Mohamed MK, Fontanet A.

Lancet Glob Health. 2014 Sep;2(9):e541-e549. doi: 10.1016/S2214-109X(14)70188-3. Epub 2014 Aug 27.

7.

Southwest Oncology Group S0802: a randomized, phase II trial of weekly topotecan with and without ziv-aflibercept in patients with platinum-treated small-cell lung cancer.

Allen JW, Moon J, Redman M, Gadgeel SM, Kelly K, Mack PC, Saba HM, Mohamed MK, Jahanzeb M, Gandara DR.

J Clin Oncol. 2014 Aug 10;32(23):2463-70. doi: 10.1200/JCO.2013.51.4109. Epub 2014 Jul 7.

8.

Apolipoprotein H expression is associated with IL28B genotype and viral clearance in hepatitis C virus infection.

Laird ME, Mohsen A, Duffy D, Mamdouh R, LeFouler L, Casrouge A, El-Daly M, Rafik M, Abdel-Hamid M, Soulier A, Pawlotsky JM, Hézode C, Rosa I, Renard P, Mohamed MK, Bonnard P, Izopet J, Mallet V, Pol S, Albert ML, Fontanet A.

J Hepatol. 2014 Oct;61(4):770-6. doi: 10.1016/j.jhep.2014.05.040. Epub 2014 Jun 4.

PMID:
24905490
9.

Is expert opinion reliable when estimating transition probabilities? The case of HCV-related cirrhosis in Egypt.

Cousien A, Obach D, Deuffic-Burban S, Mostafa A, Esmat G, Canva V, El Kassas M, El-Sayed M, Anwar WA, Fontanet A, Mohamed MK, Yazdanpanah Y.

BMC Med Res Methodol. 2014 Mar 17;14:39. doi: 10.1186/1471-2288-14-39.

10.

Effectiveness and cost-effectiveness of immediate versus delayed treatment of hepatitis C virus-infected patients in a country with limited resources: the case of Egypt.

Obach D, Deuffic-Burban S, Esmat G, Anwar WA, Dewedar S, Canva V, Cousien A, Doss W, Mostafa A, Pol S, Buti M, Siebert U, Fontanet A, Mohamed MK, Yazdanpanah Y.

Clin Infect Dis. 2014 Apr;58(8):1064-71. doi: 10.1093/cid/ciu066. Epub 2014 Feb 7.

PMID:
24510934
11.

The ABCs of viral hepatitis that define biomarker signatures of acute viral hepatitis.

Duffy D, Mamdouh R, Laird M, Soneson C, Le Fouler L, El-Daly M, Casrouge A, Decalf J, Abbas A, Eldin NS, Fontes M, Abdel-Hamid M, Mohamed MK, Rafik M, Fontanet A, Albert ML.

Hepatology. 2014 Apr;59(4):1273-82. doi: 10.1002/hep.26901. Epub 2014 Feb 18.

PMID:
24500966
12.

A novel method to identify routes of hepatitis C virus transmission.

Féray C, Bouscaillou J, Falissard B, Mohamed MK, Arafa N, Bakr I, El-Hoseiny M, Daly ME, El-Kafrawy S, Plancoulaine S, Abdel-Hamid M, Thiers V, Fontanet A.

PLoS One. 2014 Jan 23;9(1):e86098. doi: 10.1371/journal.pone.0086098. eCollection 2014.

13.

Fibroscan of chronic HCV patients coinfected with schistosomiasis.

Esmat G, Elsharkawy A, El Akel W, Fouad A, Helal K, Mohamed MK, Attia D, Khattab H, Doss W, Labib S.

Arab J Gastroenterol. 2013 Sep;14(3):109-12. doi: 10.1016/j.ajg.2013.07.001. Epub 2013 Aug 27.

PMID:
24206738
14.

Quantifying current hepatitis C virus incidence in Egypt - Response to letter by Miller and Abu-Raddad.

Breban R, Doss W, Esmat G, Elsayed M, Hellard M, Ayscue P, Albert M, Fontanet A, Mohamed MK.

J Viral Hepat. 2013 Sep;20(9):668. doi: 10.1111/jvh.12092. No abstract available.

PMID:
23910653
15.

Towards realistic estimates of HCV incidence in Egypt.

Breban R, Doss W, Esmat G, Elsayed M, Hellard M, Ayscue P, Albert M, Fontanet A, Mohamed MK.

J Viral Hepat. 2013 Apr;20(4):294-6. doi: 10.1111/j.1365-2893.2012.01650.x. Epub 2012 Sep 13.

PMID:
23490375
16.

Frequent transient hepatitis C viremia without seroconversion among healthcare workers in Cairo, Egypt.

Munier A, Marzouk D, Abravanel F, El-Daly M, Taylor S, Mamdouh R, Eldin WS, El-Arab HE, Sos DG, Momen M, Okasha O, Le Fouler L, El-Hosini M, Izopet J, Rafik M, Albert M, Abdel-Hamid M, Mohamed MK, Delarocque-Astagneau E, Fontanet A.

PLoS One. 2013;8(2):e57835. doi: 10.1371/journal.pone.0057835. Epub 2013 Feb 28.

17.

Prevalence of hepatitis B and C virus infections and their related risk factors in Libya: a national seroepidemiological survey.

Elzouki AN, Smeo MN, Sammud M, Elahmer O, Daw M, Furarah A, Abudher A, Mohamed MK.

East Mediterr Health J. 2013 Jul;19(7):589-99.

PMID:
24975303
18.

HCV burden of infection in Egypt: results from a nationwide survey.

Guerra J, Garenne M, Mohamed MK, Fontanet A.

J Viral Hepat. 2012 Aug;19(8):560-7. doi: 10.1111/j.1365-2893.2011.01576.x. Epub 2012 Feb 6.

PMID:
22762140
19.

Analysis of IL28B variants in an Egyptian population defines the 20 kilobases minimal region involved in spontaneous clearance of hepatitis C virus.

Pedergnana V, Abdel-Hamid M, Guergnon J, Mohsen A, Le Fouler L, Theodorou I, Mohamed MK, Fontanet A, Plancoulaine S, Abel L.

PLoS One. 2012;7(6):e38578. doi: 10.1371/journal.pone.0038578. Epub 2012 Jun 14.

20.

Epidemiological and virological characteristics of symptomatic acute hepatitis E in Greater Cairo, Egypt.

Delarocque-Astagneau E, Abravanel F, Moshen A, Le Fouler L, Gad RR, El-Daly M, Ibrahim EM, El-Aidy S, Lashin T, El-Hoseiny M, Izopet J, Mohamed MK, Fontanet A, Abdel Hamid M.

Clin Microbiol Infect. 2012 Oct;18(10):982-8. doi: 10.1111/j.1469-0691.2011.03727.x. Epub 2012 Jan 20.

Supplemental Content

Loading ...
Support Center